XML 73 R44.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Quarterly Financial Data (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract] |
Schedule of Quarterly Financial Information |
| First |  | Second |  | Third |  | Fourth |  |
In millions, except per share amounts | Quarter |  | Quarter |  | Quarter |  | Quarter |  | Year
2018: |  |  |  |  |  |  |  |  |
Total revenues (1) | $ | 45,743 |  |  | $ | 46,922 |  |  | $ | 47,490 |  |  | $ | 54,424 |  |  | $ | 194,579 |
Operating income (loss) (1) | 1,996 |  |  | (1,373 | ) |  | 2,574 |  |  | 824 |  |  | 4,021 |
Income (loss) from continuing operations | 998 |  |  | (2,562 | ) |  | 1,390 |  |  | (422 | ) |  | (596 | )
Net income (loss) attributable to CVS Health | 998 |  |  | (2,563 | ) |  | 1,390 |  |  | (419 | ) |  | (594 | )
Per common share data: |  |  |  |  |  |  |  |  |
Basic earnings (loss) per common share: |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Income (loss) from discontinued operations attributable to CVS Health | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Net income (loss) attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Diluted earnings (loss) per common share: |  |  |  |  |  |  |  |  |
Income (loss) from continuing operations attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Income (loss) from discontinued operations attributable to CVS Health | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Net income (loss) attributable to CVS Health | $ | 0.98 |  |  | $ | (2.52 | ) |  | $ | 1.36 |  |  | $ | (0.37 | ) |  | $ | (0.57 | )
Dividends per common share | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 2.00 |
_____________________________________________
(1) | Effective for the fourth quarter of 2018, interest income was reclassified from interest expense, net to net investment income within revenues to conform with insurance company presentation. Accordingly, a retrospective reclassification of $50 million, $214 million and $221 million was made for the first, second and third quarters of 2018, respectively, to increase revenues and increase interest expense.
| First |  | Second |  | Third |  | Fourth |  |
In millions, except per share amounts | Quarter |  | Quarter |  | Quarter |  | Quarter |  | Year
2017: |  |  |  |  |  |  |  |  |
Total revenues (1) | $ | 44,520 |  |  | $ | 45,689 |  |  | $ | 46,186 |  |  | $ | 48,391 |  |  | $ | 184,786 |
Operating income (1) | 1,799 |  |  | 2,121 |  |  | 2,504 |  |  | 3,114 |  |  | 9,538 |
Income from continuing operations | 962 |  |  | 1,097 |  |  | 1,285 |  |  | 3,287 |  |  | 6,631 |
Net income attributable to CVS Health | 952 |  |  | 1,098 |  |  | 1,285 |  |  | 3,287 |  |  | 6,622 |
Per common share data: |  |  |  |  |  |  |  |  |
Basic earnings per common share: |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health | $ | 0.93 |  |  | $ | 1.07 |  |  | $ | 1.26 |  |  | $ | 3.23 |  |  | $ | 6.48 |
Income (loss) from discontinued operations attributable to CVS Health | $ | (0.01 | ) |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (0.01 | )
Net income attributable to CVS Health | $ | 0.92 |  |  | $ | 1.07 |  |  | $ | 1.26 |  |  | $ | 3.23 |  |  | $ | 6.47 |
Diluted earnings per common share: |  |  |  |  |  |  |  |  |
Income from continuing operations attributable to CVS Health | $ | 0.92 |  |  | $ | 1.07 |  |  | $ | 1.26 |  |  | $ | 3.22 |  |  | $ | 6.45 |
Income (loss) from discontinued operations attributable to CVS Health | $ | (0.01 | ) |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | (0.01 | )
Net income attributable to CVS Health | $ | 0.92 |  |  | $ | 1.07 |  |  | $ | 1.26 |  |  | $ | 3.22 |  |  | $ | 6.44 |
Dividends per common share | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 0.50 |  |  | $ | 2.00 |
_____________________________________________
(1) | Effective for the fourth quarter of 2018, interest income was reclassified from interest expense, net to net investment income within revenues to conform with insurance company presentation. Accordingly, a retrospective reclassification of $6 million, $4 million, $5 million and $6 million was made for the first, second, third and fourth quarters of 2017, respectively, to increase revenues and increase interest expense.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a)-(j) -URI http://asc.fasb.org/extlink&oid=84173487&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration